These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients. Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573 [TBL] [Abstract][Full Text] [Related]
7. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis]. Ahn DW Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Juran BD; McCauley BM; Atkinson EJ; Schlicht EM; Bianchi JK; Vollenweider JM; Ye H; LaRusso NF; Gores GJ; Sun Z; Lazaridis KN Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39023332 [TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells. Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881 [TBL] [Abstract][Full Text] [Related]
10. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics. Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604 [TBL] [Abstract][Full Text] [Related]
11. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538 [TBL] [Abstract][Full Text] [Related]
13. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Sasatomi K; Noguchi K; Sakisaka S; Sata M; Tanikawa K J Hepatol; 1998 Sep; 29(3):409-16. PubMed ID: 9764987 [TBL] [Abstract][Full Text] [Related]
14. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR. Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856 [TBL] [Abstract][Full Text] [Related]
15. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Corpechot C; El Naggar A; Poujol-Robert A; Ziol M; Wendum D; Chazouillères O; de Lédinghen V; Dhumeaux D; Marcellin P; Beaugrand M; Poupon R Hepatology; 2006 May; 43(5):1118-24. PubMed ID: 16628644 [TBL] [Abstract][Full Text] [Related]
16. Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis. Dai L; Ye Y; Mugaany J; Hu Z; Huang J; Lu C Aging (Albany NY); 2024 May; 16(10):9228-9250. PubMed ID: 38809509 [TBL] [Abstract][Full Text] [Related]
17. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients. Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154 [TBL] [Abstract][Full Text] [Related]
20. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]